New Cosentyx® treatment can clear skin of patients with psoriasis
While there is no cure for psoriasis, an autoimmune skin disease, the science of psoriasis therapies is evolving at a very rapid pace. The recent Cosentyx® approval heralds a new era for psoriasis treatment at SkinCare Physicians’ Psoriasis Treatment Center near Boston. Cosentyx® (secukinumab), a biologic therapy developed specifically for psoriasis, is now available for adults suffering from moderate-to-severe psoriasis. This is the first of several highly anticipated “second generation” biologics to complete rigorous testing and become available to treat this significant life-impacting disease. Cosentyx® targets interleukin-17 (IL-17), one of the key chemical hormones that are elevated in people who … Continue reading